Nancy Davis

Sr. Prin. Scientist, MSD, Bladder Cancer

Tweets are my own & do not represent any organization or institution. RT are not endorsements.

[Nancy Davis @NBDavisMD]

Interesting, insightful editorial. https://t.co/vOyEIp37A9

[Toni Choueiri, MD @DrChoueiri]

I am at #GU25. Can’t miss the most important GU-directed meeting of the year from @ASCO —let us enjoy 3 days of science, clincial advancement and just a wonderful #GU community !

@jrgralow @CliffordHudis @JCO_ASCO @ASCOPres @DrRanaMcKay @montypal @DanaFarber_GU

[Katy Beckermann @katy_beckermann]

Congrats @koshkin85
✅ 41% ORR pembro retreatment
🕒 Median time between courses: 10.7 mo
⏳ mPFS: 9.5 mo | mOS: 25.7 mo
🔄 65% of responders had CR to first-course

💡 Perhaps some have inherent T effector capacity and require continued PD-1 blockade to maintain response! 🚀

[National Cancer Institute @theNCI]

Dr. W. Kimryn Rathmell will step down as @NCIDirector, effective Monday, January 20. Read Dr. Rathmell’s thoughts in her announcement below.

[Nancy Davis @NBDavisMD]

@CathyEngMD @myESMO Yes!! I am here and streaming still difficult

[Nancy Davis @NBDavisMD]

@montypal @DrChoueiri @shilpaonc @NazliDizman @Uromigos @tompowles1 @Silke_Gillessen @AmandaNizamMD @alantanmd @TDorffOnc @PGrivasMDPhD 🤣🤣

[Alan Tan @alantanmd]

The Vanderbilt University Ingram Cancer Center Genitourinary team is expanding. We are seeking a GU medical oncology clinical investigator to join our innovative team. Please message me or @brian_rini to inquire further. We will also be at #ESMO24

[SWOG Cancer Research Network @SWOG]

From @SWOG S1314: Bladder cancer tumors w changes in any of 3 DNA damage-repair genes were >5X as likely to be cleared by neoadj cisplatin-based chemo. Could help ID patients who could trade bladder removal for surveillance. Results in @EUplatinum.
https://t.co/DTmsztxPdT

[Nancy Davis @NBDavisMD]

@jordanberlin5 @Microsoft @Apple Nero was apparently very much into fine arts..acting, poetry, etc. Made him hugely unpopular with the elite. He supposedly rallied citizens into trying to fight the fire, according to some ancient historians. But popular history is written by the victors, so we know he fiddled

[Nancy Davis @NBDavisMD]

@shilpaonc @CleClinicMD @CWRUSOM @jamecancerdoc @MoffittNews @umnmedschool @neerajaiims @montypal @DrChoueiri @ERPlimackMD @sandysrimd @WesKassouf @GeneCollector @UroDocAsh @SpiessPhilippe @Prof_Nick_James Congratulations, Shilpa amd well deserved!!!🎂🥂

[OncLive.com @OncLive]

Telemedicine Allows for First-of-its-Kind Trial Administering Subcutaneous Immunotherapy at Home
@nievamd @uscnorris #oncology #MedTwitter #lcsm
https://t.co/ajlPVQ8wQR

[OncLive.com @OncLive]

First-line treatment with Versamune HPV and pembrolizumab met the primary end point of best overall response in the phase 2 VERSATILE-002 trial in HPV6–positive recurrent/metastatic HNSCC.#hnscc #oncology https://t.co/Pn3fD68zi6

[Tom Powles @tompowles1]

New @myESMO guidlines for advanced bladder cancer @Annals_Oncology. Enforumab Vedotin & pembro is the new standard of care. Platinum therapy is now 2nd line and eligibility less relevant. Gem/cis/nivo or maintenance avelumab for pts where EVP not available https://t.co/wx2AD4eEGn

[Nancy Davis @NBDavisMD]

@jordanberlin5 @VUMC_Medicine @VUMCHemOnc @KimrynRathmell @theNCI I miss you

[Kimryn Rathmell @KimrynRathmell]

Latest and greatest in GU Oncology 🧡🧡🧡, by the ones really making it happen. GU Oncology Rising ⭐️🌟⭐️🌟⭐️ 👇👇👇👇

[Nancy Davis @NBDavisMD]

@reneekmcalister @ancellkk @katy_beckermann @brian_rini @KimrynRathmell @YuWeiChenMD @Tucker_MatthewD We were doubly thankful for you (even if I didn't know what you did when I joined😆🤣). You did an amazing job for all our patients!

[Tom Powles @tompowles1]

EV302- enfortumab vedotin and Pembrolizumab met its dual primary endpoints of OS and PFS with ‘clinically meaningful’ improvement versus chemotherapy in patients with previously untreated la/mUC. https://t.co/NRb4DhQR2C

[Toni Choueiri, MD @DrChoueiri]

JUST IN: Belzutifan 005 trial from @Merck shows superior PFS/ORR compared ro everolimus ! Results are in !

https://t.co/pnID9LBRVF

[Nancy Davis @NBDavisMD]

@CathyEngMD @GillSharlene @grousemountain @HKennecke @JWMarriott Grouse is beautiful!!

[Nancy Davis @NBDavisMD]

@VUMCurology @jackson_cabo @Endo_Society @MayoClinic Congratulations!!!